[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f2m592jcto5r9n":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":4,"products":23,"patents":32,"exclusivities":33,"paragraphIv":34,"catalysts":36},"TALWIN NX","NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE","SANOFI AVENTIS US","sanofi-aventis-us",[20],"018733","none",1,[24],{"key":25,"applNo":20,"productNo":26,"dosageForm":27,"route":28,"strength":29,"approvalDate":30,"rld":13,"teCode":12,"type":31,"loe":12,"basis":21,"carveOutPossible":13},"018733-001","001","TABLET","ORAL","EQ 0.5MG BASE;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","1982-12-16","DISCN",[],[],{"asOf":12,"firstFiled":12,"entries":35},[],[]]